Relationship between exhaled nitric oxide and IgE sensitisation in patients with asthma: influence of steroid treatment.
Syk
Jörgen
J
Department of Neurobiology, Caring Sciences and Society, Karolinska Institutet, Stockholm, Sweden. jorgen.syk@ptj.se
Undén
Anna-Lena
AL
Alving
Kjell
K
D000280:Administration, Inhalation; D000293:Adolescent; D000328:Adult; D000704:Analysis of Variance; D000730:Androstadienes / Q000008:administration & dosage / Q000627:therapeutic use*; D001249:Asthma / Q000188:drug therapy* / Q000276:immunology*; D001993:Bronchodilator Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D019819:Budesonide / Q000008:administration & dosage / Q000627:therapeutic use*; D004983:Ethanolamines / Q000008:administration & dosage / Q000627:therapeutic use; D005260:Female; D000068298:Fluticasone; D000068759:Formoterol Fumarate; D005938:Glucocorticoids / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D007073:Immunoglobulin E / Q000276:immunology*; D008297:Male; D008875:Middle Aged; D009569:Nitric Oxide / Q000032:analysis* / Q000276:immunology; D011788:Quality of Life; D012129:Respiratory Function Tests; D011795:Surveys and Questionnaires
D000730:Androstadienes; D001993:Bronchodilator Agents; D004983:Ethanolamines; D005938:Glucocorticoids; D009569:Nitric Oxide; D007073:Immunoglobulin E; D019819:Budesonide; D000068298:Fluticasone; D000068759:Formoterol Fumarate